Hematologic abnormalities in severe neonatal necrotizing enterocolitis: 25 years later

Journal of Perinatology

Volumn 23, Issue 7, 2003, Pages 523-530

  Kling, Pamela J ^a   Hutter, John J ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR; CORTICOSTEROID DERIVATIVE; CYTOKINE; FRESH FROZEN PLASMA; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; HEPARIN; INTERLEUKIN 11; MELATONIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT THROMBOPOIETIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE CONCENTRATE;

ANTIINFLAMMATORY ACTIVITY; BLOOD CLOTTING DISORDER; CRYOPRECIPITATE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SAFETY; EMERGENCY SURGERY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; LEUKOPOIESIS; MALE; MEGAKARYOPOIESIS; NECROTIZING ENTEROCOLITIS; NEUTROPENIA; NEWBORN; NEWBORN DISEASE; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ENTEROCOLITIS, NECROTIZING; HEMATOLOGIC DISEASES; HUMANS; INFANT, NEWBORN;

EID: 0242456062     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210983     Document Type: Review

References (69)

1. Kliegman RM. Models of the pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117:S2-5.
2. Kosloske AM. A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr 1990;117:S68-74.
3. Hutter JJ, Hathaway WE, Wayne ER. Hematologic abnormalities in severe neonatal necrotizing enterocolitis. J Pediatr 1976;88:1026-31.
4. Patel C. Hematologic abnormalities in acute necrotizing enterocolitis. Pediatr Clin N Am 1977;24:579-84.
5. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr 1980;97:791-4.
6. Sola M, Vecchio A, Rimsza L. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Neonatal Hematol 2000;27:655-79.
7. Aronis S, Platokouki H, Photopoulos S, Eftychia A, Xanthou M. Indications of coagulation and/or fibrinolytic systems activation in healthy and sick very low birth weight neonates. Biol Neonate 1998;74:337-44.
8. Manco-Johnson M, Nuss R. Hemostasis in neonates. Neoreviews 2000;1:e191-5.
9. Caplan M, Sun X, Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-Acether). Gastroenterology 1990;99:979-86.
10. Caplan M, Kelly A, Hsueh W. Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor. Pediatr Res 1992;31:428-34.
11. Caplan M, Lickerman M, Adler L, Dietsch G, Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 1997;42:779-83.
12. Muguruma K, Gray PW, Tjoelker LW, Johnston JM. The central role of PAF in necrotizing enterocolitis development. Eicosanoids and Other Bioactive Lipids in Cancer Inflammation and Radiation Injury 1997;3:379-82.
13. Rabinowitz SS, Dzakpasu P, Piecuch S, Leblanc P, Valencia G, Kornecki E. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 2001;138:81-6.
14. Furukawa M, Narahara H, Yasuda K, Johnston J. Presence of platelet-activating factor-acetylhydrolase in milk. J Lipid Res 1993;34: 1603-9.
15. Lucas A, Cole T. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519-23.
16. Stohlawetz P, Folman C, Borne A et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 1999;81:613-7.
17. Nakashima K, Taga T, gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities. Semin Hematol 1998;35: 210-21.
18. Bruno E, Briddell RA, Cooper RJ, Hoffman R. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol 1991;19:378-81.
19. Harris MC, Costarino AT, Sullivan JS et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994;124:105-11.
20. Ledbetter DJ, Juul SE. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 2000;35:178-82.
21. Du X, Liu Q, Yang Z et al. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 1997;272: G545-52.
22. Nadler EP, Stanford A, Zhang X-R et al. Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease. J Pediatr Surg 2001;36:1122-9.
23. Oren H, Duman N, Abacioglu H, Ozkan H, Irken G. Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic and septic term neonates. Pediatrics 2001;108:329-32.
24. Kaushansky K. Thrombopoietin. N Engl J Med 1998;339:746-54.
25. Ishiguro A, Nakahata T, Matsubara K et al. Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels. Br J Haematol 1999;106:884-8.
26. Murray N, Watts T, Roberts I. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998;43:148-51.
27. Sola M, Calhoun D, Hutson A, Christiansen R. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-2.
28. Colarizi P, Fiorucci P, Caradonna A, Ficuccilli F, Mancuso M, Papoff P. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr 1999;88:332-7.
29. Gupta SK, Burke G, Herson VC. Necrotizing enterocolitis: laboratory indicators of surgical disease. J Pediatr Surg 1994;29:1472-5.
30. Schober PH, Nassiri J. Risk factors and severity indices in necrotizing enterocolitis. Acta Paediatr Suppl 1994;396:49-52.
31. Ross MN, Wayne ER, Hanson JB, Burrington JD, Chang JHT. A standard of comparison for acute surgical necrotizing enterocolitis. J Pediatr Surg 1989;24:998-1002.
32. Ververidis M, Kiely EM, Spitz L, Drake DP, Eaton S, Pierro A. The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis. J Pediatr Surg 2001;36:799-803.
33. VanGeet C, Devriendt K, Eyskens B, Vermylen J, Hoylaerts MF. Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant platelets. Pediatr Res 1998;44:607-11.
34. Andrew M, Castle V, Mitchell L, Paes B. Modified bleeding time in the infant. Am J Hematol 1989;30:190-1.
35. Rennie JM, Gibson T, Cooke RW. Micromethod for bleeding time in the newborn. JPEN 1989;13:620-2.
36. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998;24:507-12.
37. Gitto E, Karbownik M, Reiter RJ et al. Effects of melatonin treatment in septic newborns, Pediatr Res 2001;50:756-60.
38. Tapper H, Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 2000;96:2329-37.
39. Sonntag J, Wagner MH, Waldschmidt J, Wit J, Obladen M. Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birthweight infants. J Pediatr Surg 1998;33:481-4.
40. Gopel W, Christiansen B, Reiss I, Moller J, Gortner L. Resistance to activated protein C in newborns with necrotizing enterocolitis. Eur J Pediatr 1999;158:608.
41. Hathaway W, Corrigan J. Report of the scientific and standardization subcommittee on neonatal hemostasis. Thromb Haemost 1991;65: 323-5.
42. Andrew M, Paes B, Milner R et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
43. Edstrom CS, Christensen RD, Andrew M. Developmental aspects of blood hemostasis and disorders of coagulation and fibrinolysis in the neonatal period. In: Christensen RD, editor. Hematologic Problems of the Neonate. Philadelphia: Saunders; 2000. p. 239-72.
44. Kreuz W, Veldmann A, Fischer D, Schlosser R, Volk WR, Ettinghausen CE. Neonatal sepsis: a challenge in hemostaseology. Semin Thromb Hemost 1999;25:531-5.
45. Rintala E, Kauppila M, Seppala O-P et al. Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 2000;28:2373-8.
46. Bernard GR, Vincent J-L, Laterre P-F et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
47. White B, Livingstone W, Murphey C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000;96:3719-24.
48. Ettinghausen CE, Veldmann A, Beeg T, Schneider W, Jaeger G, Kreuz W. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost 1999;25:537-41.
49. Matthay MA. Severe sepsis - a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med 2001;344:759-63.
50. Fuse S, Tomita H, Yoshida M,. Hori T, Igarashi C, Fujita S. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children. Am J Hematol 1996;53:18-21.
51. Schmidt B, Gillie P, Mitchel L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:470-6.
52. Kocherlakota P, La Gamma EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 1997;100:e6.
53. Bernstein HM, Pollock BH, Calhoun DA, Christensen RD. Administration of recombinant human granulocyte colony stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr 2001;138:917-20.
54. Bilgin K, Yaramis A, Haspolat K, Tas A, Gunbey S, Derman O. A randomized trial of granulocyte - macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001;107:36-41.
55. Kling PJ, Sullivan TM, Leftwich ME, Roe DJ. Score for neonatal acute physiology predicts erythrocyte transfusions in premature infants. Arch Pediatr Adoles Med 1997;151:27-31.
56. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH.Variations in transfusion practice in neonatal intensive care. Pediatrics 1998;101:194-200.
57. Hall N, Ong EGP, Ade-Ajayi N et al. T cryptantigen activation is associated with advanced necrotizing enterocolitis. J Pediatr Surg 2002;37: 791-3.
58. Jelkmann W, Wolff M, Fandrey J. Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications. Contrib Nephrol 1990;80:68-77.
59. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1991;50:301-8.
60. Juul SE, Joyce AE, Zhao Y, Ledbetter DJ. Why is erythropoietin present in human milk? Studies of eythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999;46:263-8.
61. Kling PJ, Sullivan TM, Roberts RA, Philipps AF, Koldovsky O. Human milk as a potential enteral source of erythropoietin. Pediatr Res 1998;43: 216-21.
62. Obayashi H, Koshi S, Miyauchi Y, Inoue M. Inhibition of posthemorrhagic transfusion-induced gastric injury by a long-acting superoxide dismutase derivative. Proc Soc Exp Biol Med 1991;196:164-9.
63. Strauss RG. Practical issues in neonatal transfusion practice. Am J Clin Pathol 1997;107:S5763.
64. Atkinson SA. Human milk feeding of the micropremie. Clin Perinatol 2000;27:235-47.
65. Ledbetter DJ, Juul SE. Necrotizing enterocolitis and hematopoietic cytokines. Clin Perinatol 2000;27:697-716.
66. Bauer CR, Morrison JC, Poole WK et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984;73:682-8.
67. Halac E, Halac J, Begue EF et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990;117:132-8.
68. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:11-25.
69. Ihara Y, Frenkel RA, Johnston JM. Hormonal regulation of platelet-activating factor-acetyltransferase activity in rat tissue. Arch Biochem Biophys 1993;304:503-7.